Companies / Rose Pharma
Rose Pharma
Company
Rose Pharma is developing a novel short-acting GLP-1 therapy for severe acute IBS pain and long-term weight loss success
Rose Pharma has 2 investors on file, among them Rosetta Capital and Scientia Ventures. Its site was last checked 7 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Rosetta Capital
18 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (90%), AI & Machine Learning (5%), E-commerce & Marketplaces (5%).
See Rosetta Capital's full profile · Who invests alongside it
More from Scientia Ventures
16 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (72%), AI & Machine Learning (22%), Fintech (6%).
See Scientia Ventures' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Rose Pharma and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Rosetta Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/rosepharmainc.com/investors
# also
GET /v1/companies/rosepharmainc.com
GET /v1/companies/rosepharmainc.com/news